Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Other financing activities (2016 - 2024)

Healthequity has reported Other financing activities over the past 7 years, most recently at $4.6 million for Q4 2024.

  • Quarterly results put Other financing activities at $4.6 million for Q4 2024, up 2742.24% from a year ago — trailing twelve months through Jan 2026 was $4.3 million (up 14.57% YoY), and the annual figure for FY2025 was $3.7 million, changed.
  • Other financing activities for Q4 2024 was $4.6 million at Healthequity, up from -$282000.0 in the prior quarter.
  • Over the last five years, Other financing activities for HQY hit a ceiling of $4.6 million in Q4 2024 and a floor of -$3.3 million in Q3 2022.
  • Median Other financing activities over the past 3 years was $74000.0 (2022), compared with a mean of $347454.5.
  • Peak annual rise in Other financing activities hit 2742.24% in 2024, while the deepest fall reached 122.45% in 2024.
  • Healthequity's Other financing activities stood at -$588000.0 in 2022, then skyrocketed by 127.38% to $161000.0 in 2023, then surged by 2742.24% to $4.6 million in 2024.
  • The last three reported values for Other financing activities were $4.6 million (Q4 2024), -$282000.0 (Q3 2024), and -$546000.0 (Q2 2024) per Business Quant data.